Largactyl en es it fr

Largactyl Brand names, Largactyl Analogs

Largactyl Brand Names Mixture

  • No information avaliable

Largactyl Chemical_Formula

C17H20N2S

Largactyl RX_link

No information avaliable

Largactyl fda sheet

Largactyl msds (material safety sheet)

Largactyl Synthesis Reference

No information avaliable

Largactyl Molecular Weight

284.42 g/mol

Largactyl Melting Point

< 25 oC

Largactyl H2O Solubility

14.2 mg/L

Largactyl State

Liquid

Largactyl LogP

4.893

Largactyl Dosage Forms

Tablet; Oral liquid; Injection

Largactyl Indication

Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.

Largactyl Pharmacology

Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.

Largactyl Absorption

Absorption may be erratic and peak plasma concentrations show large interindividual differences.

Largactyl side effects and Toxicity

Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.

Largactyl Patient Information

No information avaliable

Largactyl Organisms Affected

Humans and other mammals